Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 13, Number 3—March 2007

Research

Population-based Laboratory Surveillance for AmpC β-Lactamase–producing Escherichia coli, Calgary

Johann D.D. Pitout*Comments to Author , Daniel B. Gregson*, Deirdre L. Church*, and Kevin B. Laupland*
Author affiliations: *University of Calgary, Calgary, Alberta, Canada;

Main Article

Figure 3

Age- and sex-specific incidence of AmpC β-lactamase–producing Escherichia coli isolates per 100,000 population, Calgary Health Region, 2000–2003.

Figure 3. Age- and sex-specific incidence of AmpC β-lactamase–producing Escherichia coli isolates per 100,000 population, Calgary Health Region, 2000–2003.

Main Article

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO